Default company panoramic image
Feb11d3b 0458 4c06 85e9 e921d8a5561a

TrophoMax LLC

We are an agricultural biotech company commercializing a patented natural seed & leaf inoculant based around a natural beneficial bacteria.

  • Stage Product In Development
  • Industry Biotechnology
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded September 2011
  • Employees 5
  • Website Trophomax.com

Company Summary

TrophoMax® is the brand name for a patented agricultural seed and leaf inoculant. The active ingredient is a naturally occurring family of beneficial bacteria known as PPFMs. In preliminary third party tests, when PPFMs have been applied to the seeds and leaves of certain plants, crop yield and biomass increases of 10% and higher have been observed. TrophoMax is the exclusive licensee of 6 US patents and the owner of two provisional patents.

Team

  • Default avatar
    Thomas Laurita
    President and CEO

    Thomas Laurita, MPPM/PhD, President and CEO: Entrepreneur with multiple successes growing technology, manufacturing, and financial companies from start-up to exit; 20+ years consulting experience for major agricultural multinationals; former USSR Country Manager for Monsanto.

  • Default avatar
    Stephen Kahn
    Chief Financial Officer

    Stephan Kahn MBA, Senior VP and CFO: Harvard MBA and with 17 years experience as Managing Director at Advent International (Private Equity/VC), 10 years High Tech management (CAD/CAM)

  • Default avatar
    Marc Vanacht
    VP for Business Development & Strategy

    Marc Vanacht MBA/Master of Law, VP for Business Development and Strategy: Multicultural, Belgian citizen fluent in 5 languages with 20 years managerial experience in Monsanto; 15+ years as an strategic consultant, and an internationally recognized expert and advocate on technology innovation and precision agriculture.

  • Default avatar
    Marcus Jones
    VP Product Development

    Marcus Jones PhD, VP for Product Development: until July 2012 a top PD manager, most recently at Monsanto (5 years) and Syngenta (10 years) with PhD in Crop and Soil Science from Michigan State. Deep experience in multiple cropping systems, product evaluation, seed technology, biotic/abiotic yield and stress testing, agronomy, experimental trial design.

  • Default avatar
    Michael Bielski
    VP for intellectual Property & Corp Counsel

    Mike Bielski JD/MS, VP for Intellectual Property and Corporate Counsel: lawyer specialized in IP and patent strategy focused on biotech startups; molecular biology and neuroscience background.

  • Default avatar
    Bernard Auxensfans
    Advisory Board/Consultant

    Bernard Auxenfans MS, Agricultural engineer, former COO of Monsanto Agriculture Worldwide; former President and Chairman of Monsanto Europe; a French citizen and acknowledged expert on the commercialization of agricultural inputs.

  • Default avatar
    Dilip Shah
    Advisory Board/ Consultant

    Dilip Shah PhD, world-level geneticist, Monsanto Fellow, inventor on 13 relevant patents including original glyphosate resistance patents. 18 years as Monsanto scientist, from 2001-present Principal Investigator at Danforth Plant Sciences center.

  • Default avatar
    Gregg Bogosian
    Advisory Board/ Consultant

    Gregg Bogosian PhD, winner of the prestigious Queeny Award at Monsanto. 26 years at Monsanto as senior research scientist focused on microbial biology and production. Expert Patent Witness.

  • Default avatar
    Mark Holland
    Advisory Board

    Mark Holland PhD, discoverer and patent author of the agricultural uses of PPFMs, Professor and former Chair of the Biology Department at Salisbury University (part of the University of Maryland system).

Advisors

  • Default avatar
    Powell Carmen/ Brendan Johnson -- Bryan Cave; Rick Shear --Thompson Coburn
    Lawyer
    Unconfirmed
    Default avatar
    Walsh and Associates - Concord, MA
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Angel Investors -- $850,000
    Unconfirmed